Classes
DEA Class; Rx
Common Brand Names; Avandamet
- Antidiabetics, Biguanides/Thiazolidinediones
Description
Oral combination of metformin, a biguanide, and rosiglitazone, a thiazolidinedione (TZD)
Used in adults for type 2 diabetes mellitus; rosiglitazone is not to be used with insulin
Risk of lactic acidosis due to metformin is low; TZDs may cause or exacerbate heart failure; monitor closely
Indications
Indicated for the treatment of type 2 diabetes mellitus not controlled by diet and exercise.
Contraindications
Hypersensitivity to rosiglitazone or metformin
Heart failure NYHA Class III-IV
Metabolic acidosis, including diabetic ketoacidosis with or without coma
Severe renal disease: eGFR <30 ml/min/1.73 m²
Nursing women
Adverse Effects
- Edema (6% to 25% )
- Upper respiratory infections (16-20%)
- Diarrhea (12.7% to 14%)
- Hypoglycemia (12% )
- Anemia (4% to 7%)
- Fatigue (6%)
- Headache (6%)
- Sinusitis (6%)
- Arthralgia (5%)
- Back pain (5%)
- Viral infection (5%)
- Angioedema (rare )
- Congestive heart failure
- Death, from cardiovascular causes
- Stevens-Johnson syndrome (rare )
- Lactic acidosis (rare )
- Hepatotoxicity (rare)
- Anaphylaxis (rare )
- Diabetic macular edema
- Pleural effusion
- Pulmonary edema
Metformin
- Cholestatic, hepatocellular, and mixed hepatocellular liver injury
Warnings
Risk of severe hypoglycemia especially in elderly, debilitated or malnourished, adrenal or pituitary insufficiency, dehydration, heavy alcohol use, hypoxic states, hepatic/renal impairment, stress due to infection, fever, trauma, or surgery
Rare lactic acidosis may occur due to metformin accumulation; fatal in approx 50% of cases; risk increases with age, degree of renal dysfunction, and with unstable or acute CHF; if metformin-associated lactic acidosis suspected, general supportive measures should be instituted promptly in a hospital setting, along with immediate discontinuation of therapy; in patients with a diagnosis or strong suspicion of lactic acidosis, prompt hemodialysis is recommended to correct acidosis and remove accumulated metformin (metformin hydrochloride is dialyzable, with a clearance of up to170 mL/minute under good hemodynamic conditions); hemodialysis has often resulted in reversal of symptoms and recovery
Edema; thiazolidinediones, which are peroxisome proliferator-activated receptor (PPAR) gamma agonists, can cause dose-related fluid retention, particularly when used in combination with insulin; not recommended for use with insulin
Withholding of food and fluids during surgical or other procedures may increase risk for volume depletion, hypotension, and renal impairment; therapy should be temporarily discontinued while patients have restricted food and fluid intake
Several of the postmarketing cases of metformin-associated lactic acidosis occurred in setting of acute congestive heart failure (particularly when accompanied by hypoperfusion and hypoxemia); cardiovascular collapse (shock) acute myocardial infarction, sepsis, and other conditions associated with hypoxemia have been associated with lactic acidosis and may also cause prerenal azotemia; discontinue therapy when such events occur
Therapy with thiazolidinediones may result in ovulation in premenopausal anovulatory women
Rosiglitazone: Associated with rare cases of new onset or worsening of macular edema
Pregnancy and Lactation
Pregnancy Category: C
Lactation: not known if crosses into breast milk, avoid
Maximum Dosage
8 mg/day PO rosiglitazone with 2000 mg/day PO metformin.
In general do not titrate to the adult maximum dosage of 8 mg/day PO rosiglitazone with 2000 mg/day PO metformin.
Safety and efficacy have not been established.
Safety and efficacy have not been established.
How supplied
Metformin/rosiglitazone
tablet
- 500mg/2mg
- 500mg/4mg
- 1000mg/2mg
- 1000mg/4mg